```html

Ipomoea (Morning Glory) Poisoning – A Comprehensive Medical Guide

Overview

Ipomoea, commonly known as morning glory, encompasses more than 800 species of flowering vines and shrubs. While many species are cultivated for their attractive blossoms, several contain potent psychoactive alkaloids (mainly lysergic acid amide, LSA) that can cause toxicity when ingested in large amounts.

• Who it affects: Children who mistakenly eat the seeds or foliage, adults using the seeds recreationally, and agricultural workers handling large quantities of plant material.
• Prevalence: Exact incidence is unknown because most cases are reported sporadically, but poison‑center data from the United States (American Association of Poison Control Centers, 2022) shows an average of ≈150 calls per year related to “morning glory seed ingestion”. Cases are more common in the summer months when the plants are in seed when they mature.

Although the plant is not typically lethal, the neuro‑psychoactive effects can be severe and may mimic serotonin‑syndrome–type toxicity, especially when combined with other substances.

Symptoms

Symptoms vary with the amount ingested, the specific Ipomoea species, and individual sensitivity. Onset usually occurs 30 minutes to 3 hours after ingestion.

System	Symptoms	Description
Neurologic / Psychiatric	Hallucinations, visual disturbances, altered perception of time	Patients often describe “trippy” experiences similar to LSD, with vivid colors, geometric patterns, and synesthetic sensations.
	Confusion, agitation, anxiety, panic attacks	Can range from mild nervousness to severe agitation requiring sedation.
	Vertigo, dizziness, ataxia	Impaired coordination is common and increases fall risk.
Gastrointestinal	Nausea, vomiting, abdominal cramps, diarrhea	Most frequent early sign; may be severe enough to cause dehydration.
Cardiovascular	Tachycardia, hypertension, palpitations	Reflects sympathomimetic activity of LSA.
Autonomic	Dry mouth, pupillary dilation (mydriasis), sweating	Signs of anticholinergic/serotonergic overlap.
Skin	Flushing, itching, occasional rash	Usually mild but can be confused with allergic reactions.
Severe/Life‑Threatening	Seizures, hyperthermia, rhabdomyolysis, acute kidney injury	Rare, typically seen with massive ingestion or co‑exposure to other drugs.

Causes and Risk Factors

Poisoning results from ingestion (oral), inhalation of powdered seed dust, or transdermal absorption (rare). The toxic principle is lysergic acid amide (LSA), a structural analog of LSD.

• Recreational use: In some sub‑cultures, dried seeds are consumed for hallucinogenic effects. The dose needed for psychoactivity (≈300–500 mg of seeds) often exceeds the amount that produces gastrointestinal upset.
• Accidental ingestion: Young children may eat the seeds, which resemble edible beans or candy.
• Occupational exposure: Farmworkers or gardeners handling large quantities without gloves may inadvertently ingest dust.
• Co‑ingestion with MAO inhibitors or serotonergic drugs: Increases risk of serotonin syndrome.

Risk factors include age < 12 years, pre‑existing psychiatric disorders, pregnancy (due to unknown fetal effects), and concurrent use of other hallucinogens.

Diagnosis

Diagnosis is primarily clinical, supported by a focused history and targeted investigations.

1. History taking: Ask about recent ingestion of seeds, plant material, or “herbal” preparations. Note the time interval, estimated amount, and concomitant substances.
2. Physical examination: Look for mydriasis, tachycardia, hypertension, skin flushing, and neurologic deficits.
3. Laboratory tests (ordered based on severity):
   • Basic metabolic panel – assess electrolytes, renal function.
   • Creatine kinase – detect rhabdomyolysis.
   • Serum drug screen – immunoassays may not detect LSA, but they rule out co‑ingested substances.
   • Urine toxicology – specialized LC‑MS/MS can identify LSA, though rarely available in community labs.
4. Electrocardiogram (ECG): Evaluate for QT prolongation or arrhythmias, especially if other stimulants are involved.
5. Imaging (rarely needed): CT or MRI brain if seizures or focal neurologic signs persist.

Treatment Options

There is no specific antidote for LSA. Management focuses on supportive care and symptom control.

Acute care

• Gastrointestinal decontamination – If presentation is within 1 hour of ingestion and the airway is protected, administer activated charcoal (1 g/kg, max 50 g). Gastric lavage is not routinely recommended.
• Hydration – Intravenous isotonic fluids (e.g., normal saline) to prevent hypotension and aid renal clearance.
• Control of agitation / psychosis – Low‑dose benzodiazepines (e.g., lorazepam 1‑2 mg IV) are first‑line. For severe psychosis, antipsychotics (haloperidol) may be used cautiously.
• Seizure management – Benzodiazepines; if refractory, consider levetiracetam or fosphenytoin.
• Hyperthermia – Aggressive cooling (ice packs, evaporative cooling) and antipyretics.
• Cardiovascular monitoring – Treat hypertension with short‑acting agents (e.g., labetalol). Beta‑blockers are avoided if severe tachycardia with bronchospasm is present.
• Renal protection – Monitor urine output; treat rhabdomyolysis with alkalinized fluids if CK > 5,000 U/L.

Long‑term / follow‑up

• Psychiatric evaluation: Recommended for anyone who used the seeds recreationally or exhibits persistent anxiety, depression, or substance‑use disorder.
• Education: Counseling on the risks of plant‑derived hallucinogens.
• Rehabilitation programs: May be indicated for repeated misuse.

Living with Ipomoea (Morning Glory) Poisoning

Most individuals recover fully within 24‑48 hours after supportive care. However, those with recurrent exposure or chronic psychiatric sequelae need ongoing strategies.

• Medical follow‑up: Schedule a visit 1‑2 weeks after discharge to assess renal function, mental health status, and any lingering neurologic symptoms.
• Medication adherence: If benzodiazepines were prescribed for anxiety, use the lowest effective dose and taper under supervision.
• Support networks: Encourage participation in support groups (e.g., Narcotics Anonymous) if substance misuse is a concern.
• Home safety: Keep garden seeds out of reach of children; store them in sealed containers.
• Nutrition: Maintain a balanced diet and adequate hydration to assist organ recovery.

Prevention

1. Education of caregivers and school personnel about the visual similarity of morning‑glory seeds to edible beans.
2. Labeling of garden seed packets with clear warnings about toxicity.
3. Protective equipment for agricultural workers – gloves, masks, and eye protection when handling mature seed pods.
4. Public health messaging during planting season (late spring to early fall), especially in regions where Ipomoea species are invasive (e.g., southeastern United States).
5. Regulation: Some jurisdictions classify high‑dose seed packets as “controlled substances” for recreational use; awareness of local laws can deter misuse.

Complications

If left untreated or if massive ingestion occurs, serious complications can arise:

• Serotonin syndrome – Hyperthermia, rigidity, autonomic instability; may be precipitated when LSA is taken with SSRIs or MAO inhibitors.
• Acute kidney injury – Resulting from dehydration, rhabdomyolysis, or direct nephrotoxicity.
• Seizure‑related injuries – Falls, head trauma.
• Persistent psychiatric disturbances – Hallucinogen persisting perception disorder (HPPD) characterized by visual disturbances lasting weeks to months.
• Cardiovascular events – Rarely, ventricular arrhythmias or myocardial ischemia in predisposed individuals.

When to Seek Emergency Care

References

1. Mayo Clinic. “Morning Glory (Ipomoea) poisoning.” Updated 2023. https://www.mayoclinic.org
2. American Association of Poison Control Centers. “Annual Report of Poison Center Data.” 2022.
3. Cleveland Clinic. “Lysergic Acid Amide (LSA) Toxicity.” 2022.
4. National Institute on Drug Abuse. “Hallucinogens: Overview.” 2021.
5. World Health Organization. “Guidelines for the Management of Acute Poisoning.” 2020.
6. CDC. “Botanical Toxicants – Plant Poisonings.” 2021.

```